SUPACEF Side Effects

6087330-5 | Bronchospasm, Choking Sensation, Dermatitis Contact, Dyspnoea, Face Oedema, Flushing, Hyperhidrosis, Laryngeal Oedema, Ocular Hyperaemia
on Feb 17, 2009 Male patient from INDIA , 73 years of age, weighting 165.3 lb, was diagnosed with typhoid fever and was treated with Supacef (View Usage). Patient experienced the following unwanted or unexpected effects: bronchospasm, choking sensation, dermatitis contact, dyspnoea, face oedema, flushing, hyperhidrosis, laryngeal oedema, ocular hyperaemia. Supacef dosage: 750mg Per Day. During the same period patient was treated with CEFUROXIME AXETIL (250mg Twice Per Day) (View Cefuroxime Axetil Review and Cefuroxime Axetil Label ), OFLOXACIN (400mg Per Day) (View Ofloxacin Review and Ofloxacin Label ).

6080567-0 | Anaphylactic Shock, Back Pain, Hypotension, Loss Of Consciousness, Product Quality Issue
Patient was taking Supacef (View Usage). Patient had the following side effects: anaphylactic shock, back pain (What is back pain?), hypotension, loss of consciousness, product quality issue on Feb 12, 2009 from INDIA Additional patient health information: Female patient , 55 years of age, weighting 141.1 lb, was diagnosed with prophylaxis and. Supacef dosage: 1.5g Single Dose. Patient was hospitalized.

6072171-5 | Anaphylactic Shock, Back Pain, Hypotension, Loss Of Consciousness, Product Quality Issue
Adverse event was reported on Feb 09, 2009 by a Female patient taking Supacef (View Usage) (Dosage: 1.5g Single Dose) was diagnosed with prophylaxis and. Location: INDIA , 55 years of age, weighting 141.1 lb, After Supacef was administered, patient had the following side effects: anaphylactic shock, back pain (What is back pain?), hypotension, loss of consciousness, product quality issue. Patient was hospitalized.

6064608-2 | Anaphylactic Shock, Product Quality Issue
on Jan 27, 2009 Female patient from INDIA , 55 years of age, was diagnosed with prophylaxis and was treated with Supacef (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock, product quality issue. Supacef dosage: . Patient was hospitalized.


6034424-6 | Bronchospasm, Choking Sensation, Dermatitis Contact, Dyspnoea, Face Oedema, Flushing, Hyperhidrosis, Laryngeal Oedema, Ocular Hyperaemia
on Jan 08, 2009 Male patient from INDIA , 73 years of age, weighting 165.3 lb, was treated with Supacef (View Usage). Patient had the following side effects: bronchospasm, choking sensation, dermatitis contact, dyspnoea, face oedema, flushing, hyperhidrosis, laryngeal oedema, ocular hyperaemia. Supacef dosage: 750mg Per Day. During the same period patient was treated with CEFUROXIME AXETIL (250mg Twice Per Day) (View Cefuroxime Axetil Review and Cefuroxime Axetil Label ), OFLOXACIN (400mg Per Day) (View Ofloxacin Review and Ofloxacin Label ).

6029971-7 | Bronchospasm, Choking Sensation, Dermatitis Contact, Dyspnoea, Face Oedema, Flushing, Hyperhidrosis, Laryngeal Oedema, Ocular Hyperaemia
Patient was taking Supacef (View Usage). After Supacef was administered, patient had the following side effects: bronchospasm, choking sensation, dermatitis contact, dyspnoea, face oedema, flushing, hyperhidrosis, laryngeal oedema, ocular hyperaemia on Jan 06, 2009 from INDIA Additional patient health information: Male patient , 73 years of age, weighting 165.3 lb, . Supacef dosage: 750mg Per Day. During the same period patient was treated with CEFUROXIME AXETIL (250mg Twice Per Day) (View Cefuroxime Axetil Review and Cefuroxime Axetil Label ), OFLOXACIN (400mg Per Day) (View Ofloxacin Review and Ofloxacin Label ).

5959833-2 | Bronchospasm, Choking Sensation, Dermatitis Contact, Dyspnoea, Face Oedema, Flushing, Hyperhidrosis, Laryngeal Oedema, Ocular Hyperaemia
Adverse event was reported on Nov 20, 2008 by a Male patient taking Supacef (View Usage) (Dosage: 750mg Per Day) . Location: INDIA , 73 years of age, weighting 165.3 lb, Patient experienced the following unwanted or unexpected effects: bronchospasm, choking sensation, dermatitis contact, dyspnoea, face oedema, flushing, hyperhidrosis, laryngeal oedema, ocular hyperaemia. During the same period patient was treated with CEFUROXIME AXETIL (250mg Twice Per Day) (View Cefuroxime Axetil Review and Cefuroxime Axetil Label ), OFLOXACIN (400mg Per Day) (View Ofloxacin Review and Ofloxacin Label ).

5958082-1 | Bronchospasm, Choking Sensation, Dermatitis Contact, Dyspnoea, Face Oedema, Flushing, Hyperhidrosis, Laryngeal Oedema, Ocular Hyperaemia
on Nov 11, 2008 Male patient from INDIA , 73 years of age, weighting 165.3 lb, was treated with Supacef (View Usage). Patient had the following side effects: bronchospasm, choking sensation, dermatitis contact, dyspnoea, face oedema, flushing, hyperhidrosis, laryngeal oedema, ocular hyperaemia. Supacef dosage: 750mg Per Day. During the same period patient was treated with CEFTAZIDIME (250mg Twice Per Day) (View Ceftazidime Review and Ceftazidime Label ), OFLOXACIN (400mg Per Day) (View Ofloxacin Review and Ofloxacin Label ).

5920520-8 | Flushing, Ocular Hyperaemia, Respiratory Arrest, Sneezing
on Oct 08, 2008 Female patient from INDIA , 73 years of age, was treated with Supacef (View Usage). After Supacef was administered, patient had the following side effects: flushing, ocular hyperaemia, respiratory arrest, sneezing. Supacef dosage: 250mg Per Day.

5787935-2 | Chills
Patient was taking Supacef (View Usage). Patient experienced the following unwanted or unexpected effects: chills on Jun 18, 2008 from INDIA Additional patient health information: Male patient , 22 years of age, was diagnosed with prophylaxis and. Supacef dosage: 170mg Per Day. During the same period patient was treated with AMIKACIN (View Amikacin Review and Amikacin Label ). Patient was hospitalized.

5728765-7 | Anaphylactic Shock, Circulatory Collapse
Adverse event was reported on May 06, 2008 by a Female patient taking Supacef (View Usage) (Dosage: 1.5g Single Dose) . Location: INDIA , 56 years of age, Patient had the following side effects: anaphylactic shock, circulatory collapse. Patient was hospitalized.

5591844-1 | Hyperbilirubinaemia
on Jan 14, 2008 Male patient from INDIA , 50 years of age, was treated with Supacef (View Usage). After Supacef was administered, patient had the following side effects: hyperbilirubinaemia. Supacef dosage: .

5591843-X | Hyperbilirubinaemia
on Jan 14, 2008 Male patient from INDIA , 63 years of age, was treated with Supacef (View Usage). Patient experienced the following unwanted or unexpected effects: hyperbilirubinaemia. Supacef dosage: .

5591842-8 | Hyperbilirubinaemia
Patient was taking Supacef (View Usage). Patient had the following side effects: hyperbilirubinaemia on Jan 14, 2008 from INDIA Additional patient health information: Male patient , 76 years of age, . Supacef dosage: .

5591841-6 | Hyperbilirubinaemia
Adverse event was reported on Jan 14, 2008 by a Male patient taking Supacef (View Usage) (Dosage: ) . Location: INDIA , 78 years of age, After Supacef was administered, patient had the following side effects: hyperbilirubinaemia.

5591840-4 | Hyperbilirubinaemia
on Jan 14, 2008 Male patient from INDIA , 49 years of age, was treated with Supacef (View Usage). Patient experienced the following unwanted or unexpected effects: hyperbilirubinaemia. Supacef dosage: .

4664584-0 | Anaphylactic Reaction, Blood Pressure Immeasurable, Bronchospasm, Cardiac Arrest, Chest Discomfort, Cyanosis, Dyspnoea, Loss Of Consciousness, Pulse Absent
on Apr 25, 2005 Female patient from , 32 years of age, weighting 242.5 lb, was diagnosed with hypertension, hypothyroidism, ill-defined disorder and was treated with Supacef (View Usage). Patient had the following side effects: anaphylactic reaction, blood pressure immeasurable, bronchospasm, cardiac arrest (What is cardiac arrest?), chest discomfort, cyanosis, dyspnoea, loss of consciousness, pulse absent. Supacef dosage: . During the same period patient was treated with BUPIVACAINE (View Bupivacaine Review and Bupivacaine Label ), INSULIN (View Insulin Review and Insulin Label ), METHYLDOPA (125mg Three Times Per Day) (View Methyldopa Review and Methyldopa Label ), THYROXINE SODIUM (.1mg Per Day) (View Thyroxine Sodium Review and Thyroxine Sodium Label ), DERIPHYLLINE (View Deriphylline Review and Deriphylline Label ), GLYCOPYRROLATE (View Glycopyrrolate Review and Glycopyrrolate Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ). Patient was hospitalized.